Pharma

Pharmalot Ed Silverman

STAT Plus: Many docs who tweeted product endorsements also took money from manufacturers, analysis shows

The Readout Elaine Chen

STAT Plus: Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a deal for a Moderna bird flu shot, NIH trial shortcomings, and more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Merck deal, weight loss drugs, and lots more

The Readout Elaine Chen

STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study

Pharma Andrew Joseph

STAT Plus: Looking to expand its pipeline, Merck to buy eye-disease startup EyeBio

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about the Cencora data breach, a failed pandemic treaty, and more

The Readout Meghana Keshavan

STAT Plus: Biotech’s most interesting fundraisings from the last week

Pharmalot Adam Feuerstein

STAT Plus: Pharmalittle: We’re watching more positive data for Ozempic, a Lilly factory expansion, and more

The Readout Meghana Keshavan

STAT Plus: More tumult at BIO amid the company’s fourth CEO in four years

Pharma Olivia Goldhill

STAT Plus: After MDMA therapy, she considered suicide. The trial data tell a different story

The Readout Elaine Chen

STAT Plus: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu

Pharmalot Matthew Herper

STAT Plus: Pharmalittle: We’re watching a Cytokinetics deal with Royalty Pharma, Cue Health shutting down, and more

Biotech Allison DeAngelis and Elaine Chen

STAT Plus: Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy

The Readout Elaine Chen

STAT Plus: Maryland takes first steps to cap drug costs

Pharmalot Jonathan Wosen

STAT Plus: Pharmalittle: We’re watching a ban of compounded versions of GLP-1s, a Biogen acquisition, and more

Pharmalot Allison DeAngelis

STAT Plus: Pharmalittle: We’re watching BIO layoffs, AstraZeneca plans to double revenue, and more

The Readout Elaine Chen

STAT Plus: Lilly doubles down on radiopharma

The Readout Meghana Keshavan

STAT Plus: The biotech news you need to read this morning

Pharmalot Andrew Joseph

STAT Plus: Pharmalittle: We’re reading about Sanders’ pharma pressure campaign, AstraZeneca’s new ADC factory, and more

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about an Amgen drug for lung cancer, a Novo plant fire, and more

The Readout Meghana Keshavan

AstraZeneca antibody reduced Covid-19 risk in immunocompromised

Pharma Matthew Herper

STAT Plus: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Roche obesity drug, an experimental Lilly insulin, and more

The Readout Elaine Chen

STAT Plus: Blackstone wants in on red-hot immunology market

Pharma Andrew Joseph

STAT Plus: Obesity drug from Roche succeeds in early test, sending company shares up

Pharmalot Ed Silverman

STAT Plus: Getting abortion pills through the mail is safe, quick, and effective, study finds

The Readout Elaine Chen

STAT Plus: Leqembi gets closer to being offered as an injection